SM_223b: Reproductive Pharmacology Flashcards
Describe the reproductive axis
Reproductive axis
- Reproductive hormones: GnRH, gonadotropins, estrogen, progesterone, testosterone
- Therapeutic applications: reproductive hormones for therapy, drugs that impact reproductive axis
Describe agonists
Agonist
- Binds receptor
- Physiological conformational change
- Hormone-like physiologic response
Describe antagonists
Antagonist
- Binds receptor
- Non-physiological conformational change
- No physiologic response
Describe selective receptor modulators
Selective receptor modulators
- Tissue-specific agonist or antagonist activity
- Mechanisms: differential expression of receptor in target tissues, differential conformational shape with receptor binding, and differential expression of co-regulators in target tissues
Describe different conformational shapes in binding to the ER
Different conformational shapes in binding to the ER
- ER + estradiol: gene transcription ON
- ER + raloxifene: gene transcription OFF
SERMs activate ____ and ____
SERMs activate co-repressors and co-activators
Describe enzyme inhibitors
Enzyme inhibitors
- Testosterone (biosynthetic pathways): estradiol is a potent estrogen, dihydrotestosterone is a potent androgen
- 5-alpha reductase converts testosterone to dihydrotestosterone, hair follicles in male genitalia
- Aromatase converts androgens to estrogens, in ovary / brain / bone / liver / fat
Prolactin ___ the reproductive axis
Prolactin inhibits the reproductive axis
- Decreased GnRH pulses
- Inhibits LH: no ovulation, inadequate corpus luteum
- Adaptive: avoid pregnancy while lactating
- Treatment goal: decrease prolactin levels
Describe symptoms of hyperprolactinemia
Hyperprolactinemia
- Women: galactorrhea, menstrual irregularity, infertility
- Men: galactorrhea, impotence, visual field abnormalities, headache, extraocular muscle weakness, anterior pituitary malfunction
Dopamine is an endogenous prolactin ___
Dopamine is an endogenous prolactin inhibitor
Dopamine agonists (bromocriptine, cabergoline) ___ and ___
Dopamine agonists (bromocriptine, cabergoline) decrease prolactin secretion and decrease the size of prolactinomas
- Restore menstrual cycles and fertility
- Cabergoline is specific D2 receptor agonist that is long acting and has fewer GI side effects
Polycystic ovary syndrome results from ___
Polycystic ovary syndrome results from excess androgen from the ovary
- Follicles do not convert from androgenic to estrogenic milieu
- Dominant follicle is not selected
- No ovulation
- Treatment goal: increase FSH to increase aromatase, decrease testosterone
Describe actions of clomiphene citrate
Clomiphene citrate
- Increases endogenous estrogen
- Anti-estrogen in brain, cervical mucus, endometrium
- Leads to increased FSH due to perceived low estrogen, stimulates follicles (may be > 1), increases estrogen, causes ovulation
Describe actions of tamoxifen
Tamoxifen
- Reduces incidence of breast cancer
- Also induces ovulation
- Biological action depends on cell type
- Anti-estrogenic in breast, leads to hot flashes
- Estrogenic: venous thrombosis, maintains bone density, vaginal mucosa, endometrium (increases risk of endometrial cancer)
Describe actions of aromatase inhibitor
Aromatase inhibitor
- Blocks estrogen production: decreases negative feedback, leads to increased FSH -> follicle development
- Adjuvant treatment for breast cancer
- Short half-life and decreased anti-estrogenic effects (better endometrium) compared to clomiphene
Insulin ____ androgen production from theca cells, particularly in PCOS patients
Insulin increases androgen production from theca cells, particularly in PCOS patients
____ is best for ovulation induction in PCOS
Clomiphene plus metformin is best for ovulation induction in PCOS
Anovulation with PCOS has clinical consequences of ____, ____, and ____
Anovulation with PCOS has clinical consequences of
- Endometrial cancer: due to continuous estrogen without periodic progesterone
- Menstrual disturbances: 50% amenorrhea, 30% dysfunctional uterine bleeding
- Infertility